| Source of Chronic Inflammation in Aging |
54 |
| Loss of Metabolic Flexibility in the Failing Heart |
35 |
| Mechanisms and Consequences of Defective efferocytosis in Atherosclerosis |
34 |
| Endothelial-Vascular Smooth Muscle Cells Interactions in Atherosclerosis |
28 |
| Vascular Senescence in Cardiovascular and Metabolic Diseases |
27 |
| 3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications |
25 |
| Pulse Wave Velocity in Atherosclerosis |
23 |
| Extracellular Vesicles as Biomarkers in Cardiovascular Disease; Chances and Risks |
22 |
| Platelet-Neutrophil Interplay: Insights Into Neutrophil Extracellular Trap (NET)-Driven Coagulation in Infection |
21 |
| Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options |
20 |
| Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease |
20 |
| Roles and Regulation of Extracellular Vesicles in Cardiovascular Mineral Metabolism |
20 |
| The Role of Macrophages in the Infarcted Myocardium: Orchestrators of ECM Remodeling |
19 |
| Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution? |
18 |
| Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis |
18 |
| Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure |
18 |
| Antiinflammatory Therapy in Clinical Care: The CANTOS Trial and Beyond |
18 |
| Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities |
18 |
| Mouse Models for Atherosclerosis Research-Which Is My Line? |
18 |
| Tissue Specific Origin, Development, and Pathological Perspectives of Pericytes |
17 |
| Deciphering Non-coding RNAs in Cardiovascular Health and Disease |
17 |
| Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease |
17 |
| Cardiac Complications in Immune Checkpoint Inhibition Therapy |
16 |
| Endogenous Calcification Inhibitors in the Prevention of Vascular Calcification: A Consensus Statement From the COST Action EuroSoftCalcNet |
16 |
| Effects of Exercise to Improve Cardiovascular Health |
16 |
| Transplantation of Hearts Donated after Circulatory Death |
16 |
| Cardiomyocyte-Endothelial Cell Interactions in Cardiac Remodeling and Regeneration |
16 |
| The Role of the TGF-beta Superfamily in Myocardial Infarction |
15 |
| Common Methods for Performing Mendelian Randomization |
15 |
| Cardiotoxicity of Anticancer Therapeutics |
15 |
| Inflammation in Vein Graft Disease |
15 |
| Long QT Syndrome and Sinus Bradycardia-A Mini Review |
15 |
| Relevance of Multi-Omics Studies in Cardiovascular Diseases |
14 |
| The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model |
14 |
| Arterial Stiffness: A Prognostic Marker in Coronary Heart Disease. Available Methods and Clinical Application |
14 |
| Connected Health in Hypertension Management |
14 |
| Myocarditis in Humans and in Experimental Animal Models |
14 |
| Takes Two: Endothelial-Perivascular Cell Cross-Talk in Vascular Development and Disease |
13 |
| Vasculoprotective Role of Olive Oil Compounds via Modulation of Oxidative Stress in Atherosclerosis |
13 |
| Kruppel-Like Factors in vascular inflammation: Mechanistic insights and Therapeutic Potential |
13 |
| Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles |
13 |
| Long Noncoding RNA ANRIL: Lnc-ing Genetic Variation at the Chromosome 9p21 Locus to Molecular Mechanisms of Atherosclerosis |
13 |
| Heterocellularity and Cellular Cross-Talk in the Cardiovascular System |
13 |
| Recent Advances in Short QT Syndrome |
13 |
| Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes |
12 |
| Can We Grow Valves Inside the Heart? Perspective on Material-based In Situ Heart Valve Tissue Engineering |
12 |
| Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy? |
12 |
| Role of Platelet Mitochondria: Life in a Nucleus-Free Zone |
11 |
| Radiation Matters of the Heart: A Mini Review |
11 |
| Cell Phenotype Transitions in Cardiovascular Calcification |
11 |
